{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:30:15Z","timestamp":1773286215243,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T00:00:00Z","timestamp":1333152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10552-012-9946-5","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T10:51:59Z","timestamp":1333104719000},"page":"769-777","source":"Crossref","is-referenced-by-count":41,"title":["Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden"],"prefix":"10.1007","volume":"23","author":[{"given":"Bo","family":"Attner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Landin-Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Lithman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"issue":"Suppl 1","key":"9946_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1055\/s-2008-1081488","volume":"116","author":"D LeRoith","year":"2008","unstructured":"LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4\u2013S6","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"9946_CR2","first-page":"269","volume":"1","author":"M Mori","year":"2000","unstructured":"Mori M, Saitoh S, Takagi S, Obara F, Ohnishi H, Akasaka H et al (2000) A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer. Asian Pac J Cancer Prev 1(4):269\u2013276","journal-title":"Asian Pac J Cancer Prev"},{"key":"9946_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-78818-0_6","volume":"630","author":"A Hjartaker","year":"2008","unstructured":"Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72\u201393","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"9946_CR4","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674\u20131685 [Epub 2010\/07\/01]","journal-title":"Diabetes Care"},{"issue":"4","key":"9946_CR5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103\u20131123 [Epub 2009\/07\/22]","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"9946_CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829\u2013841 [Epub 2011\/03\/04]","journal-title":"N Engl J Med"},{"key":"9946_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nu.12.070192.002135","volume":"12","author":"S Kritchevsky","year":"1992","unstructured":"Kritchevsky S (1992) Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12:391\u2013416","journal-title":"Annu Rev Nutr"},{"issue":"1\u20132","key":"9946_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-005-2993-4","volume":"268","author":"V Michalaki","year":"2005","unstructured":"Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268(1\u20132):19\u201324","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"9946_CR9","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1158\/1055-9965.EPI-08-1248","volume":"18","author":"J Ahn","year":"2009","unstructured":"Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11):2814\u20132821 [Epub 2009\/11\/06]","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"9946_CR10","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1158\/1055-9965.EPI-09-1027","volume":"18","author":"EJ Jacobs","year":"2009","unstructured":"Jacobs EJ, Gapstur SM (2009) Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 18(11):2805\u20132806 [Epub 2009\/11\/06]","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"9946_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/14034940601086646","volume":"34","author":"MF Drummond","year":"2006","unstructured":"Drummond MF, Botten G, Hakkinen U, Pedersen KM (2006) Assessing the quality of Swedish health economics research. Scand J Public Health 34(6):566\u2013570 [Epub 2006\/11\/3]","journal-title":"Scand J Public Health"},{"issue":"1","key":"9946_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27\u201333 [Epub 2008\/09\/04]","journal-title":"Acta Oncol"},{"key":"9946_CR13","first-page":"1","volume":"11","author":"The National Board of Health and Welfare","year":"2008","unstructured":"The National Board of Health and Welfare (2008) Cancer incidence in Sweden 2007. Health Dis 11:1\u2013117","journal-title":"Health Dis"},{"issue":"11","key":"9946_CR14","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, de Gonzalez AB, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076\u20132083 [Epub 2005\/05\/12]","journal-title":"Br J Cancer"},{"key":"9946_CR15","doi-asserted-by":"crossref","unstructured":"Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2010) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control [Epub 2010\/11\/26]","DOI":"10.1007\/s10552-010-9686-3"},{"issue":"7","key":"9946_CR16","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/ijc.25794","volume":"129","author":"JM Genkinger","year":"2010","unstructured":"Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2010) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129(7):1708\u20131717 [Epub 2010\/11\/26]","journal-title":"Int J Cancer"},{"issue":"9","key":"9946_CR17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","volume":"52","author":"HM Colhoun","year":"2009","unstructured":"Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52(9):1755\u20131765 [Epub 2009\/07\/16]","journal-title":"Diabetologia"},{"issue":"9","key":"9946_CR18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","volume":"52","author":"LG Hemkens","year":"2009","unstructured":"Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, Selke GW et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52(9):1732\u20131744 [Epub 2009\/07\/01]","journal-title":"Diabetologia"},{"issue":"9","key":"9946_CR19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","volume":"52","author":"JM Jonasson","year":"2009","unstructured":"Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies\u2014a population-based follow-up study in Sweden. Diabetologia 52(9):1745\u20131754 [Epub 2009\/07\/10]","journal-title":"Diabetologia"},{"issue":"9","key":"9946_CR20","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2337\/dc10-0476","volume":"33","author":"E Mannucci","year":"2010","unstructured":"Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C et al (2010) Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 33(9):1997\u20132003 [Epub 2010\/06\/17]","journal-title":"Diabetes Care"},{"issue":"2","key":"9946_CR21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13813450902878054","volume":"115","author":"S Becker","year":"2009","unstructured":"Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115(2):86\u201396","journal-title":"Arch Physiol Biochem"},{"issue":"3","key":"9946_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1358\/mf.2006.28.3.985230","volume":"28","author":"R Schiel","year":"2006","unstructured":"Schiel R, Beltschikow W, Steiner T, Stein G (2006) Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28(3):169\u2013175","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"7503","key":"9946_CR23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304\u20131305","journal-title":"BMJ"},{"issue":"9","key":"9946_CR24","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","volume":"52","author":"U Smith","year":"2009","unstructured":"Smith U, Gale EA (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52(9):1699\u20131708 [Epub 2009\/07\/15]","journal-title":"Diabetologia"},{"issue":"Suppl 6","key":"9946_CR25","first-page":"81","volume":"59","author":"R Siekmeier","year":"2008","unstructured":"Siekmeier R, Scheuch G (2008) Inhaled insulin\u2014does it become reality? J Physiol Pharmacol 59(Suppl 6):81\u2013113","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"9946_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","volume":"47","author":"S Bonovas","year":"2004","unstructured":"Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071\u20131078","journal-title":"Diabetologia"},{"issue":"11","key":"9946_CR27","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","volume":"15","author":"JS Kasper","year":"2006","unstructured":"Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(11):2056\u20132062 [Epub 2006\/11\/23]","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"9946_CR28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/aje\/kwp003","volume":"169","author":"KM Waters","year":"2009","unstructured":"Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169(8):937\u2013945","journal-title":"Am J Epidemiol"},{"issue":"6","key":"9946_CR29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ijc.24044","volume":"124","author":"JS Kasper","year":"2009","unstructured":"Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124(6):1398\u20131403","journal-title":"Int J Cancer"},{"issue":"10","key":"9946_CR30","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00125-008-1114-9","volume":"51","author":"TM Frayling","year":"2008","unstructured":"Frayling TM, Colhoun H, Florez JC (2008) A genetic link between type 2 diabetes and prostate cancer. Diabetologia 51(10):1757\u20131760","journal-title":"Diabetologia"},{"key":"9946_CR31","doi-asserted-by":"crossref","unstructured":"Chu DI, Freedland SJ (2010) Metabolic risk factors in prostate cancer. Cancer [Epub 2010\/12\/01]","DOI":"10.1002\/cncr.25749"},{"issue":"9612","key":"9946_CR32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569\u2013578","journal-title":"Lancet"},{"issue":"6","key":"9946_CR33","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","volume":"132","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132(6):2208\u20132225 [Epub 2007\/05\/15]","journal-title":"Gastroenterology"},{"issue":"1","key":"9946_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1467-789X.2009.00613.x","volume":"11","author":"Y Ning","year":"2009","unstructured":"Ning Y, Wang L, Giovannucci EL (2009) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19\u201330 [Epub 2009\/06\/23]","journal-title":"Obes Rev"},{"issue":"1","key":"9946_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/02841868809090315","volume":"27","author":"SA Tornberg","year":"1988","unstructured":"Tornberg SA, Holm LE, Carstensen JM (1988) Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27(1):31\u201337 [Epub 1988\/01\/01]","journal-title":"Acta Oncol"},{"issue":"8","key":"9946_CR36","first-page":"2341","volume":"50","author":"LJ Vatten","year":"1990","unstructured":"Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50(8):2341\u20132346 [Epub 1990\/04\/15]","journal-title":"Cancer Res"},{"issue":"1","key":"9946_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/88.1.32","volume":"88","author":"KJ Helzlsouer","year":"1996","unstructured":"Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW (1996) Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 88(1):32\u201337 [Epub 1996\/01\/03]","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9946_CR38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ije\/dyr130","volume":"40","author":"T Bj\u00f8rge","year":"2011","unstructured":"Bj\u00f8rge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T et al (2011) Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol 40(6):1667\u20131677 [Epub 2011\/10\/11]","journal-title":"Int J Epidemiol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9946-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-012-9946-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9946-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T09:23:20Z","timestamp":1561541000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-012-9946-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["9946"],"URL":"https:\/\/doi.org\/10.1007\/s10552-012-9946-5","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]}}}